к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling

Citations Over TimeTop 19% of 2013 papers

Abstract

Opioids are effective analgesics for the management of moderate to severe cancer pain. Here we show that κ opioid receptor (KOR) agonists act as anti-angiogenic factors in tumors. Treatment with KOR agonists, U50,488H and TRK820, significantly inhibited human umbilical vein endothelial cell (HUVEC) migration and tube formation by suppressing VEGFR2 expression. In contrast, treatment with a μ opioid receptor agonist, DAMGO, or a δ opioid receptor agonist, SNC80, did not prevent angiogenesis in HUVECs. Lewis lung carcinoma (LLC) or B16 melanoma grafted in KOR knockout mice showed increased proliferation and remarkably enhanced tumor angiogenesis compared with those in wild type mice. On the other hand, repeated intraperitoneal injection of TRK820 (0.1-10 μg/kg, b.i.d.) significantly inhibited tumor growth by suppressing tumor angiogenesis. These findings indicate that KOR agonists play an important role in tumor angiogenesis and this knowledge could lead to a novel strategy for cancer therapy.

Related Papers

• → Feeding responses to μ-, δ- and κ-opioid receptor agonists in the meat-type chick(2004)39 cited
• → Absence of G‐protein activation by μ‐opioid receptor agonists in the spinal cord of μ‐opioid receptor knockout mice(1999)57 cited
• → Antisense oligodeoxynucleotide to a δ-opioid receptor selectivily blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouse(1994)60 cited
• → The μ-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist(2006)16 cited
• Bioassay of new sysnthesized opioid receptor ligands~#triangle open#(2001)